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Abstract
Introduction The risk that hip preserving surgery may
negatively influence the performance and outcome of
subsequent total hip replacement (THR) remains a concern.
The aim of this study was to identify any negative impact
of previous hip arthroscopy on THR.
Methods Out of 1271 consecutive patients who under-
went primary THR between 2005 and 2009, 18 had pre-
viously undergone ipsilateral hip arthroscopy. This study
group (STG) was compared with two control groups (CG,
same approach, identical implants; MCG, paired group
matched for age, BMI and Charnley categories). Operative
time, blood loss, evidence of heterotopic bone and implant
loosening at follow-up were compared between the STG
and the MCG. Follow-up WOMAC were compared
between the three groups.
Results Blood loss was not found to be significantly
different between the STG and MCG. The operative time
was significantly less (p \ 0.001) in the STG. There was
no significant difference in follow-up WOMAC between
the groups. No implant related complications were noted in
follow-up radiographs. Two minor complications were
documented for the STG and three for the MCG.
Conclusion We have found no evidence that previous hip
arthroscopy negatively influences the performance or short-
term clinical outcome of THR.
Keywords Hip  Arthroscopy  Total hip prosthesis 
Outcome
Introduction
Femoroacetabular impingement (FAI) is a well recognized
intra-articular pathology causing hip pain and secondary
osteoarthritis among young adults [1–7]. Advances in sur-
gical techniques such as surgical dislocation of the hip, hip
arthroscopy, reverse periacetabular osteotomy and proximal
femoral osteotomy, provide the surgeon with effective and
safe tools to correct some of the underlying anatomical
issues [8–17]. Over the past decade, hip arthroscopy surgery
(HAS) has gained widespread popularity and its results are
claimed to be comparable with other conservative hip
procedures [18, 19]. Due to its minimally invasive nature,
and as indications have broadened, HAS has become more
frequently employed as a palliative surgical option. While
there is fair evidence in the literature for the use of
arthroscopy for FAI, there is also conflicting evidence
regarding hip arthroscopy for the treatment of mild and
moderate osteoarthritis [20]. Despite palliative hip
arthroscopy, progression of the degenerative process may
still result in end-stage arthritis, and as every surgical
approach to the hip traumatizes the musculoligamentous
complex, concern remains as to whether previous hip joint-
preserving surgery hinders future total hip replacement
(THR) and whether the long-term outcome of THR may be
impaired. Periacetabular osteotomy, for instance, seems not
to compromise the results of THR and may even improve its
outcome in dysplastic hips [21, 22]. Conversely, there is
evidence that the implantation of a total hip arthroplasty
may be more difficult after a previous corrective femoral
osteotomy, though the long term results published provide
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conflicting data[23–28]. There are no data available
regarding the outcomes of THR after surgical hip disloca-
tion or hip arthroscopy. Therefore, the purpose of this study
was to identify any negative impact of previous hip
arthroscopy on the performance and clinical result of THR.
Patients and methods
Study group
All consecutive patients, who underwent primary THR
between January 2005 and December 2009, were identified
from our computerized institutional database. All data in
this database are entered prospectively. Out of these 1271
patients, 21 had previously undergone ipsilateral hip
arthroscopy. Three patients were excluded because of
earlier ipsilateral open hip surgery prior to hip arthroscopy.
The remaining 18 patients were included and represented
the study group (STG) comprising five men and thirteen
women with an average age of 46 years (range 36–74). In
three patients, the hip arthroscopy was not performed in our
institute. In all the cases, the indication for hip arthroscopy
was FAI In two of the 13 cases, FAI was secondary to
Perthes disease and partial osteonecrosis of the femoral
head, respectively.
The arthroscopic procedure consisted of combined
femoral osteochondroplasty and acetabular trimming in
nine cases. In three cases, a femoral osteochondroplasty and
in six cases, an acetabular trimming alone was performed.
Reasons for arthroscopic failure and conversion to THR
were progression of pre-existing degenerative changes
already seen on X-rays prior to arthroscopy. In five cases,
no degeneration of the hip joint was present before
arthroscopy. All five of these patients had a postoperative
arthro-MRI because of persisting pain. In two patients,
oedema of the femoral head was identified and considered
a complication of arthroscopy and responsible for residual
pain. In one case, there were new degenerative changes of
the cartilage in the weight bearing zone, which was also
considered a complication of arthroscopy. In two patients,
repeat arthroscopy was performed because of residual
impingement and tendinitis of the iliopsoas tendon,
respectively. However, the post-operative follow-up was
unfavourable in both cases. These five patients who con-
tinued to suffer significant hip pain and remained dissat-
isfied were finally offered THR after an average time of
16 months (range 8–21) following the index procedure.
Oedema of the femoral head was identified in two
patients. Other complications such as fracture of the fem-
oral neck, heterotopic ossification, neuropathy of the
pudendal or lateral femoral cutaneous nerve were not
encountered in this series.
For all THPs in the study group, a minimally invasive
anterior approach [29] was performed and cementless
implants {Medacta: Versafit cup, Quadra stem (10 cases);
Zimmer: Fitmore cup, Fitmore stem (6 cases); Stryker:
Trident cup, Accolade stem (1 case)} were used for all but
one patient who received a hybrid replacement {Zimmer:
Fitmore cup, Exafit stem Palacos G}.
Control groups
In order to evaluate the results of the study group, two
control groups were identified from our database for
comparison. First, out of the total pool of 1,271 patients,
who underwent primary THR, all the patients in whom a
minimally invasive anterior approach was performed were
identified (1,269 cases) and 489 chosen as control group
(CG) because they had already been enrolled in a pro-
spective follow up study. In all of them, the same implant
(Medacta; Versafit cup; Quadra stem) was used. Second,
a paired matched (age, BMI, and Charnley categories [30])
control group (MCG; n = 36) was formed.
Evaluation
As indicators of THR performance and complexity, oper-
ation time, intraoperative blood loss, intra- and early post-
operative complications were evaluated and compared
between the study and the matched control groups. Addi-
tionally, standard anteroposterior and cross table lateral
views one year after surgery were used to grade eventual
heterotopic ossifications according to Brooker [31] and
report implant complications. To determine subjective
patient outcome, the WOMAC [32], recorded at least
1 year post operatively, were assessed for all groups and
compared.
Statistical analyses were performed by a statistical
consultant. The paired Wilcoxon signed-rank test was used
to compare preoperative values with those at the time of
follow-up. The Mann–Whitney U test and Chi-Square test
were performed to compare the three groups. The level of
significance was set at p \ 0.05.
Results
Demographics of the STG and MCG were statistically
equivalent and summarized in Table 1
Recorded blood loss was not different between the STG
(625 ml ± 372, range 100–150) and the MCG (693 ml ±
287, range 250–1600; Fig. 1). The operative time in the
MCG (166 ± 39 min, range 110–265) was significantly
higher (p [ 0.001) than in the STG (118 ± 31 min, range
60–170; Fig. 2).
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Two minor complications were in encountered in the
STG. One patient had a superficial wound infection due to
a suture granuloma that resolved with antibiotic therapy.
The post-operative X-ray of the second patient showed that
one of the cup screws was unduly long and had penetrated
the inner table of the ilium. Revision surgery was under-
taken the same day to replace the screw. Three minor
complications were observed in the MCG. In one patient, a
small perforation of the quadrilateral plate was needed to
be augmented with bone taken from the removed femoral
head during the same surgery. An intraoperative fracture of
the greater trochanter occurred in the second patient and
was treated with touch weight bearing for 6 weeks and
healed uneventfully. In the third patient, an early anterior
dislocation was reduced under general anaesthesia without
recurrence.
Heterotopic ossification Class 1, according to Brooker
[31] was present in one patient (6%) in the study group and
in eight patients (22%) in the MCG. The heterotopic
ossification was asymptomatic and clinically irrelevant in
all patients. No cases of implant loosening or failure were
identified.
The mean follow-up of the STG, MCG and CG was
24.4 months (SD ± 15.1; range 12–54), 18.7 months
(SD ± 13.2; range 12–54) and 14.2 months (SD ± 8.1;
range 12–54), respectively. Although the difference in
follow-up time between the STG and the MCG was not
significant (p = 0.094), follow-time of the CG was sig-
nificantly shorter (p \ 0.001) The WOMAC scores showed
no significant difference (p = 0.875) between the STG
(1.5 ± 2.3, range 0–7.7) and the CG (1.2 ± 1.5, range
0–7.7), nor between the STG and the MCG (1.3 ± 1.6,
range 0–6.1; p = 0.667; Fig. 3).
Discussion
Due to its minimally invasive nature, indications for HAS
have broadened over time, and it has become more fre-
quently employed as a palliative surgical option. In the
setting of pre-existent degenerative joint disease and when
the goal of the HAS is palliative, the benefit-to-risk ratio
Table 1 Demographics of study and matched control group
Demographics STG MCG p-value
Number 18 36 na
Age 46.3 50.4 0.087
BMI 23.9 24.7 0.196
Charnley Classification (A:B:C) 11:6:1 17:16:3 0.744
Fig. 1 Boxplot of intraoperative blood loss of study group and
matched control group
Fig. 2 Boxplot of operative time of study group and matched control
group
Fig. 3 Boxplot of 14 months follow-up WOMAC of study group,
matched control group and control group
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must be carefully weighed and discussed in detail with
each individual patient in order to keep the rate of early
conversion to THR as low as possible.
In addition the possible impact of previous HAS on the
technical aspects and outcome of THR should be consid-
ered. From a morphological point of view, one might not
expect HAS making THR more difficult, but potential
scarring and persistent postoperative inflammation could
theoretically have some influence. Such a negative influ-
ence on the performance and outcome of total hip
replacement could potentially be important in clarifying the
indications for arthroscopic hip surgery, particularly palli-
ative indications. This study aimed to evaluate this concern
and to our knowledge is the first of its kind.
In the present investigation, intraoperative blood loss,
surgical time, intra-and post-operative complications,
occurrence of heterotopic ossifications and short term
implant failures were used as measures of potential com-
plexity of THR after previous hip arthroscopy. With
respect to these parameters, previous HAS was not asso-
ciated with any negative impact when compared to a group
of primary THR without previous surgery, or a matched
control group.
The WOMAC was used as a measure of subjective
outcome and did not reveal an inferior outcome for THR
performed after previous hip arthroscopy.
This study has some limitations. First, the size of the
study group appears small. Nevertheless, for an equivalent
difference of 2.5 in the WOMAC and 300 ml for Intraop-
erative blood loss, power analysis resulted in 97 and 89%
power, respectively, when a significance level of 0.05 was
assumed.
Second, only a short-term outcome is reported in our
study. However, numerous published studies show that [33–
35] quality of life and outcome scores after THR reach a
plateau after 12–18 months and it is therefore unlikely that
the average WOMAC scores would change in any clinically
significant manner after a mean follow-up of 14 months.
Third, when compared to the MCG, we were surprised
to find a shorter operative time was recorded for THR in
the STG. Though perhaps not the complete explanation, we
feel this is likely because the senior surgeon was concerned
about the failed HAS and was focussed on a precise and
efficient THR surgery at the expense of time spent teaching
the residents. It is however recognized that while the
duration of hip arthroplasty is significantly higher for
orthopaedic trainees than senior surgeons, there are no
significant differences in outcome and complication rates.
[36, 37] and hence we do not expect this limitation to
relevantly bias our results.
We therefore conclude that, previous ipsilateral hip
arthroscopy surgery does not appear to negatively influence
the performance or outcome of subsequent THR.
Conflict of interest The authors declare that they have no conflict
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